Cargando…
Modulation of hepatic stellate cells by Mutaflor(®) probiotic in non-alcoholic fatty liver disease management
BACKGROUND: NAFLD and NASH are emerging as primary causes of chronic liver disease, indicating a need for an effective treatment. Mutaflor® probiotic, a microbial treatment of interest, was effective in sustaining remission in ulcerative colitis patients. OBJECTIVE: To construct a genetic-epigenetic...
Autores principales: | Hany, Noha M., Eissa, Sanaa, Basyouni, Manal, Hasanin, Amany H., Aboul-Ela, Yasmin M., Elmagd, Nagwa M. Abo, Montasser, Iman F., Ali, Mahmoud A., Skipp, Paul J., Matboli, Marwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338485/ https://www.ncbi.nlm.nih.gov/pubmed/35907883 http://dx.doi.org/10.1186/s12967-022-03543-z |
Ejemplares similares
-
Evaluation of the role of kefir in management of non-alcoholic steatohepatitis rat model via modulation of NASH linked mRNA-miRNA panel
por: Salah, Noha, et al.
Publicado: (2023) -
mRNA-miRNA-lncRNA Regulatory Network in Nonalcoholic Fatty Liver Disease
por: Matboli, Marwa, et al.
Publicado: (2021) -
Virtual versus paper-based PBL in a pulmonology course for medical undergraduates
por: Elnaga, Heba H. Abo, et al.
Publicado: (2023) -
Rosavin Ameliorates Hepatic Inflammation and Fibrosis in the NASH Rat Model via Targeting Hepatic Cell Death
por: Albadawy, Reda, et al.
Publicado: (2022) -
Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
por: Park, Soo-Kyung, et al.
Publicado: (2022)